Amit M Algotar, MD, PhD, MPH
Cancer Prevention and Control Program
Biography
Physician-scientist with clinical practice focusing on cancer survivorship, obesity medicine and primary care. My research training is in clinical epidemiology and cancer biology that allows me to conduct patient centered clinical research.
Cancer Focus
Cancer survivorship, treating late and long-term effects of malignancy and its treatment, using lifestyle modalities to address cancer survivorship needs such as metabolic abnormality, fatigue and sarcopenic obesity.
Selected Publications
Algotar, A., C-H. Hsu, H. H. Sherry Chow, S. Dougherty, H. M. Babiker, D. Marrero, I. Abraham, R. Kumar, J. Ligibel, K. S. Courneya, et al., "Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP): Protocol for a Feasibility and Exploratory Efficacy Study in Men on Androgen Deprivation Therapy.", JMIR Res Protoc, vol. 8, issue 2, pp. e12579, 2019 Feb 05. PMID: 30720441
Algotar, A. M., R. Behnejad, P. Singh, P. A. Thompson, C. H. Hsu, and S. P. Stratton, "EFFECT OF SELENIUM SUPPLEMENTATION ON PROTEOMIC SERUM BIOMARKERS IN ELDERLY MEN.", J Frailty Aging, vol. 4, issue 2, pp. 107-10, 2015. PMCID: PMC4567258 PMID: 26366377
Algotar, A. M., R. Behnejad, S. M Stratton, and S. P. Stratton, "Chronic use of NSAIDs and/or statins does not affect PSA or PSA velocity in men at high risk for prostate cancer.", Cancer Epidemiol Biomarkers Prev, vol. 23, issue 10, pp. 2196-8, 2014 Oct. PMCID: PMC4532431 PMID: 25060669
Nagle, R. B., A. M. Algotar, C. C. Cortez, K. Smith, C. Jones, U. G. Sathyanarayana, S. Yun, J. Riley, D. Nagy, R. Dittamore, et al., "ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma.", Prostate, vol. 73, issue 11, pp. 1233-40, 2013 Aug. PMCID: PMC4038303 PMID: 23653096
Algotar, A. M., S. M Stratton, F. R. Ahmann, J. Ranger-Moore, R. B. Nagle, P. A. Thompson, E. Slate, C. H. Hsu, B. L. Dalkin, P. Sindhwani, et al., "Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.", Prostate, vol. 73, issue 3, pp. 328-35, 2013 Feb 15. PMCID: PMC4086804 PMID: 22887343